A new rapid blood test for newborns could potentially detect genetic mutations linked to thousands of rare diseases all at ...

Each time a cell divides, its telomeres grow shorter. When they become too short, the cell can no longer replicate. This ...

Ambry Genetics was the first commercial laboratory to begin offering clinical diagnostic exome sequencing testing in 2011 3, which may bring new hope to thousands of patients and families searching ...

Wilson's new company, Philadelphia-based Gemma Biotherapeutics, plans to start testing gene therapies in Brazil this year.

The MUSC Weight Management Center (WMC) is casting a lifeline to plus-sized individuals at wit's end with their apple cider ...

B12 deficiency in pregnancy, especially in the context of a diet high in ultra-processed foods, can disturb how fat is processed and increase systemic inflammation. This raises the risk of long-term ...

Food safety inspections are being scaled back and the public was not notified after an investigation into E. coli ...

Research shows B12 deficiency in pregnancy, especially alongside ultra-processed diets, can raise long-term risks for both mother and child.

The proteinase k market is expected to reach approximately USD 30.2 million in 2025 and expand to around USD 48.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the ...

Every year, the Forbes Midas List highlights the venture capitalists whose savvy investments have shaped the tech landscape.

Nucleome Therapeutics (‘Nucleome’ or ‘the Company’), a biotechnology company harnessing the power of non-coding human genetics to discover first-in-class antibody treatments for inflammatory diseases, ...

Roche and Broad Clinical Labs collaborate to accelerate adoption of cutting-edge SBX sequencing technology: Basel Saturday, May 24, 2025, 10:00 Hrs [IST] Roche announced a strateg ...